News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Heal-Or Announces Auspicious Results Of Clinical Trials With Its Leading Product (HO-03-03) For Curing Chronic Wounds


12/21/2006 6:49:50 PM

Heal-Or, (www.healor.com) a biopharmaceutical company focused on the development of therapeutics for wound healing and various skin disorders announces auspicious results of phase I clinical trials with its leading product "HO-03-03" for curing chronic wounds, that are currently conducted in 3 medical centers in Israel. The company has recently begun the regulatory practice necessary for receiving FDA approval to conduct clinical trials in the US.

Read at NewsRx

comments powered by Disqus
NewsRx
Heal-Or
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES